raw-material (API) supply problems — e.g. “Dificultades para obtener materia prima en el mercado” (Peru)
causes not stated by the regulator — e.g. “No se tiene más interés de continuar la comercialización del producto” (Peru)
manufacturing problems — e.g. “Modificaciones en el procedimiento de fabricación,Dificultades para obtener materia prima en el mercado” (Peru)
distribution issues — e.g. “Problemas de importación” (Peru)
Frequently asked questions
Is Dimenhidrinato currently in shortage?
Yes. As of the latest regulator updates, Dimenhidrinato has 12 active shortage notices across 1 country (Peru). Status is refreshed daily from official regulatory sources.
Why is Dimenhidrinato in shortage?
Regulators attribute the current Dimenhidrinato shortages to raw-material (API) supply problems, causes not stated by the regulator, manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Dimenhidrinato shortage be resolved?
Regulator-estimated resolution dates currently range from 1 Mar 2022 to 21 Jan 2030, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Dimenhidrinato shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Dimenhidrinato status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.